(lp0
S'Interpace Diagnostics Participates in USA Today Endocrine Health Campaign Yahoo Finance - 16 hours ago PARSIPPANY, N.J., March 20, 2017 /PRNewswire/ -- Interpace Diagnostics Group, Inc. , a fully integrated commercial company that provides clinically useful molecular diagnostic tests and pathology services, today announced its participation in a&nbsp;...'
p1
aS'Interpace Diagnostics Announces Agreement with Blue Cross Blue Shield (BCBS ... PR Newswire  - Jan 3, 2017 PARSIPPANY, N.J., Jan. 3, 2017 /PRNewswire/ -- Interpace Diagnostics Corp. , a company that provides clinically useful molecular diagnostic tests and pathology services for evaluating risks of cancer, announced today that the Company&nbsp;...'
p2
aS'Interpace Diagnostics to Present New Data on Thyroid Product Performance PR Newswire  - Feb 27, 2017 27, 2017 /PRNewswire/ -- Interpace Diagnostics Group, Inc. , a fully integrated commercial company that provides clinically useful molecular diagnostic tests and pathology services, announced today the acceptance of four posters to be&nbsp;...'
p3
aS'Interpace Diagnostics Group Announces 1-for-10 Reverse Split PR Newswire  - Dec 28, 2016 PARSIPPANY, N.J., Dec. 28, 2016 /PRNewswire/ -- Interpace Diagnostics Group, Inc.  , a company that provides clinically useful molecular diagnostic tests and pathology services for evaluating ...Services Stocks Worth Chasing: JC Penney Company, Inc. , Interpace ... - The Independent Republic'
p4
aS'Interpace Diagnostics Announces New Aetna Coverage Policy PR Newswire  - Dec 8, 2016 PARSIPPANY, N.J., Dec. 8, 2016 /PRNewswire/ -- Interpace Diagnostics Corp. , a company that provides clinically useful molecular diagnostic tests and pathology services, announced today that Aetna, the third largest health plan in the&nbsp;...'
p5
aS'Interpace Diagnostics Group, Inc.  Analyst Opinion And Outlook Post Analyst - 15 hours ago Interpace Diagnostics Group, Inc.  traded at an unexpectedly low level on 03/17/2017 when the stock experienced a 6.13% gain to a closing price of $2.25.The Interpace Diagnostics Group Inc  Short Interest Update - Petro Global News 24Wall Street Ratings Review on Interpace Diagnostics Group, Inc. (:IDXG ... - Rives Journal'
p6
aS'Interpace Diagnostics Announces New York State Approval of ThyGenX for ... PR Newswire  - Oct 5, 2016 PARSIPPANY, N.J., Oct. 5, 2016 /PRNewswire/ -- Interpace Diagnostics Corp. , a company that provides specialized molecular diagnostic tests and pathology services, announced today that the New York State Department of Health has&nbsp;...'
p7
aS'Shares in Focus: Interpace Diagnostics Group, Inc.  Baxter Review - 7 hours ago Interpace Diagnostics Group, Inc.  currently has a Gross Margin  ratio of -0.012096. Robert Novy-Marx has provided investors with insights on finding high-quality value stocks.'
p8
aS'Interpace Diagnostics Launches New Services for Indeterminate Thyroid Nodules PR Newswire  - Oct 13, 2016 PARSIPPANY, N.J., Oct. 13, 2016 /PRNewswire/ -- Interpace Diagnostics Group , a company that provides specialized molecular diagnostic tests and pathology services for evaluating risk of cancer, completed the validation and launch of two&nbsp;...'
p9
aS'Interpace Diagnostics Group Inc. MarketWatch - Dec 23, 2015 Interpace Diagnostics Group Inc. NASDAQ: IDXG. GO. Set Alerts &middot; Find a Broker &middot; Join TD Ameritrade &middot; Market Index &middot; Overview Profile News Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders.'
p10
a.